PT81018B - Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine - Google Patents

Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine

Info

Publication number
PT81018B
PT81018B PT81018A PT8101885A PT81018B PT 81018 B PT81018 B PT 81018B PT 81018 A PT81018 A PT 81018A PT 8101885 A PT8101885 A PT 8101885A PT 81018 B PT81018 B PT 81018B
Authority
PT
Portugal
Prior art keywords
benzazepine
tetrahydro
chloro
methyl
preparing
Prior art date
Application number
PT81018A
Other languages
English (en)
Other versions
PT81018A (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of PT81018A publication Critical patent/PT81018A/pt
Publication of PT81018B publication Critical patent/PT81018B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT81018A 1984-09-05 1985-08-23 Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine PT81018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/647,552 US4541954A (en) 1984-09-05 1984-09-05 Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Publications (2)

Publication Number Publication Date
PT81018A PT81018A (en) 1985-09-01
PT81018B true PT81018B (en) 1987-06-24

Family

ID=24597406

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81018A PT81018B (en) 1984-09-05 1985-08-23 Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine

Country Status (19)

Country Link
US (1) US4541954A (pt)
EP (1) EP0174118A3 (pt)
JP (1) JPS6168469A (pt)
KR (1) KR860002470A (pt)
AU (1) AU581918B2 (pt)
CA (1) CA1244017A (pt)
DK (1) DK379985A (pt)
EG (1) EG17149A (pt)
ES (1) ES8609266A1 (pt)
FI (1) FI853255L (pt)
GR (1) GR852041B (pt)
HU (1) HU194181B (pt)
IL (1) IL76100A0 (pt)
NO (1) NO853255L (pt)
NZ (1) NZ213141A (pt)
PH (1) PH20796A (pt)
PT (1) PT81018B (pt)
ZA (1) ZA856268B (pt)
ZW (1) ZW13385A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
CA2100678A1 (en) * 1991-12-06 1993-06-07 Hiroshi Kagawa Film type battery and layer-built film type battery
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN101274911B (zh) 2003-06-17 2011-01-26 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
JP5270167B2 (ja) 2004-12-21 2013-08-21 アリーナ ファーマシューティカルズ， インコーポレイテッド （ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンザゼピン塩酸塩の結晶形
KR20130087622A (ko) * 2004-12-23 2013-08-06 아레나 파마슈티칼스, 인크. 5ｈｔ２ｃ 수용체 조정물질 조성물 및 그의 사용 방법
CN101466684B (zh) * 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
WO2008070111A2 (en) * 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2009111004A1 (en) * 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
KR20150070249A (ko) 2012-10-09 2015-06-24 아레나 파마슈티칼스, 인크. 체중 관리 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4251660A (en) * 1978-08-10 1981-02-17 Smithkline Corporation Method for preparing tetrahydroisoquinolines
US4200754A (en) * 1979-02-02 1980-04-29 Smithkline Corporation Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
IE53962B1 (en) * 1981-11-27 1989-04-26 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists
ZA827887B (en) * 1981-11-27 1983-11-30 Smithkline Beckman Corp Pharmaceutical compositions and method of producing alpha2 antagonism
EP0080779B1 (en) * 1981-11-27 1986-07-16 Smithkline Beckman Corporation 3-benzazepines as alpha-2 antagonists

Also Published As

Publication number Publication date
PH20796A (en) 1987-04-14
PT81018A (en) 1985-09-01
DK379985D0 (da) 1985-08-21
DK379985A (da) 1986-03-06
HU194181B (en) 1988-01-28
EG17149A (en) 1989-06-30
NO853255L (no) 1986-03-06
IL76100A0 (en) 1985-12-31
EP0174118A2 (en) 1986-03-12
ZA856268B (en) 1986-07-30
AU4648185A (en) 1986-03-13
ES546285A0 (es) 1986-09-01
GR852041B (pt) 1985-12-19
EP0174118A3 (en) 1986-12-30
ZW13385A1 (en) 1985-11-20
JPS6168469A (ja) 1986-04-08
CA1244017A (en) 1988-11-01
FI853255L (fi) 1986-03-06
US4541954A (en) 1985-09-17
ES8609266A1 (es) 1986-09-01
HUT38617A (en) 1986-06-30
AU581918B2 (en) 1989-03-09
NZ213141A (en) 1988-07-28
FI853255A0 (fi) 1985-08-23
KR860002470A (ko) 1986-04-26

Similar Documents

Publication Publication Date Title
EP0212161A3 (en) Process for preparing 1,5-diazido-3-nitrazapentane
PT81018B (en) Method for preparing 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h-3--benzazepine
CS326886A2 (en) Process for preparing 1,3,5-triazintriones
BG40963A3 (en) Method for preparing 1, 3- disubstituted 2- oxyindols
PT80956A (en) Process for preparing 1,4-dihydropyridines
HUT39168A (en) Process for preparing 1,3-oxazolidin-2-one-derivatives
YU18185A (en) Process for preparing new 1,3,2-dioxaborinanes
DE3564940D1 (en) Method for preparing 2,2,6,6-tetramethyl-4-oxopiperidine
EG17682A (en) Process for preparing 4,4-dialkyl-2-azetidinones
EP0174375A4 (en) PRODUCTION PROCESS FOR N-ACYLPHENYLALANINE.
PT80104B (en) Process for preparing 1,2,4-triazacycloalkadiene derivatives
DE3560069D1 (en) Process for preparing 2,6-dichloro-4-nitro-aniline
HUT38906A (en) Process for preparing 1,3-oxyacyl-2-oxindole derivatives
GB2176777B (en) Method for preparing 2,2,6,6-tetramethyl-4-oxopiperidine
DE3566539D1 (en) Process for preparing 2,2,6,6-tetramethyl-4-oxopiperidine
BG37292A1 (en) Method for preparing 5- pregnen- 3- beta, 17 alpha- diol- 20- oh- 3- acetate
BG37284A1 (en) Method for preparing trans- 3- amino- 2- hydroxy- 1, 2, 3, 4- hydronaphthalene
BG37076A3 (en) Method for preparing 5, 6- dihydro- 2- methyl- n- phenyl- 1, 4- oxatyine- 3- carboxamide
HUT37934A (en) Process for preparing 1,4-dihydro-pyridina derivatives
BG37293A1 (en) Method for preparing 16- brom- 5- pregnen- 3 beta, 17 alpha- diol- 20- oh- 3- acetate
BG39706A1 (en) Method for preparing 1, 1- diphenyl- ethane- 1- ols
HUT38902A (en) Process for preparing 15 /r+s/-fluor-11,15-dideoxy-prostaglandin e under 1
BG36411A1 (en) Method for preparing n- metoxymethyl- 2', 6'- dialkyl- chloracetanilides
BG37397A1 (en) Method for preparing phytospermoagglutines
BG36836A1 (en) Method for preparing n- benzoyl- n- phenylhydroxylamine